Intrepid Financial Planning Group LLC Cara Therapeutics, Inc. Transaction History

Intrepid Financial Planning Group LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$0.6 - $1.65 $600 - $1,650	-1,000 Reduced 8.7%	10,500 $7,000
Q4 2022 Feb 02, 2023	SELL	$8.88 - $12.77 $26,640 - $38,310	-3,000 Reduced 20.69%	11,500 $123,000
Q2 2022 Aug 15, 2022	BUY	$7.45 - $13.84 $108,025 - $200,680	14,500 New	14,500 $132,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14.5M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Intrepid Financial Planning Group LLC, based on Form 13F filings with the SEC.

Stay updated on Intrepid Financial Planning Group LLC with notifications on news.